Fusobacterium nucleatum and Its Impact on Colorectal Cancer Chemoresistance: A Meta-Analysis of In Vitro Co-Culture Infections
Open Access
Abstract
Introduction: Fusobacterium nucleatum, a common oral microbe associated with periodontal disease, has emerged as a significant prognostic indicator in colorectal cancer (CRC). This organism is notably enriched in CRC tissues and is associated with reduced survival times and relapse. Fusobacterium is implicated in encouraging the development of chemoresistance through diverse tumor-promoting pathways that are increasingly being elucidated across molecular domains. Methods: This work uses a combined analysis of public data examining the role of F. nucleatum in CRC by investigating multiple transcriptomic datasets derived from co-culture infections in vitro. Results: In tandem with previously identified mechanisms known to be influenced by F. nucleatum, this analysis revealed that the bacterium activates multiple chemoresistance-associated pathways, including those driving inflammation, immune evasion, DNA damage, and metastasis. Notably, this study uncovered a novel induction of type I and type II interferon signaling, suggesting activation of a pseudo-antiviral state. Furthermore, pathway analysis (IPA) predicted altered regulation of several therapeutic agents, suggesting that F. nucleatum may compromise drug efficacy through transcriptional reprogramming. Conclusions: These findings reinforce the role of F. nucleatum in modulating host cellular pathways and support the hypothesis that bacterial association potentiates chemoresistance.Keywords
This publication has 77 references indexed in Scilit:
- Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistanceFunctional & Integrative Genomics, 2025
- Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancerBreast Cancer Research and Treatment, 2024
- Tumor necrosis factor superfamily signaling: life and death in cancerCancer and Metastasis Reviews, 2024
- Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and CancersCurrent Oncology Reports, 2024
- Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseasesMolecular and Cellular Biochemistry, 2024
- The role of tumor-associated macrophages in tumor immune evasionJournal of Cancer Research and Clinical Oncology, 2024
- Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future successAdvances in Cancer Biology - Metastasis, 2024
- Identification of CCL20 as a Key Biomarker of Inflammatory Responses in the Pathogenesis of Intracerebral HemorrhageInflammation, 2023
- The Microbiome as a Component of the Tumor Microenvironment2020
- Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathwayMedical Oncology, 2015